多囊性肝病的临床试验
总计241485个结果
-
Radboud University Medical Center招聘中
-
Radboud University Medical CenterAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)完全的
-
Radboud University Medical CenterIpsen完全的
-
Radboud University Medical CenterIpsen未知
-
University Medical Center GroningenRadboud University Medical Center招聘中
-
Mayo ClinicNovartis; National Center for Research Resources (NCRR)完全的
-
Palladio BiosciencesCentessa Pharmaceuticals plc终止
-
University of North Carolina, Chapel HillNational Institute of General Medical Sciences (NIGMS)完全的
-
Assistance Publique - Hôpitaux de ParisIPSEN pharmaceutical company, Boulogne-Billancourt, France完全的
-
Cambridge University Hospitals NHS Foundation TrustAddenbrookes Charitable Trust; PKD Charity; British Renal Society & British Kidney Patient Association完全的
-
University of PittsburghNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National Institutes...完全的
-
Andreas L. Serra未知
-
Sanofi终止
-
Mario Negri Institute for Pharmacological ResearchOtsuka Pharmaceutical Italy S.r.l.完全的
-
Otsuka Pharmaceutical Development & Commercialization...完全的
-
Kadmon Corporation, LLC完全的
-
National Cancer Institute (NCI)撤销晚期成人原发性肝癌 | 局部不可切除的成人原发性肝癌 | 复发性成人原发性肝癌 | 复发性肝外胆管癌 | 不可切除的肝外胆管癌 | II期胆囊癌 | IIIA期胆囊癌 | IIIB期胆囊癌 | IVA 期胆囊癌 | IVB 期胆囊癌 | 肝外胆管胆管癌 | 胆囊腺癌 | 腺癌伴胆囊鳞状化生 | 成人原发性胆管细胞癌 | 转移性肝外胆管癌
-
Otsuka Pharmaceutical Europe Ltd未知
-
University Medical Center GroningenRadboud University Medical Center; Erasmus Medical Center; Leiden University Medical Center未知
-
Mario Negri Institute for Pharmacological Research完全的
-
Palladio BiosciencesCentessa Pharmaceuticals plc终止
-
AceLink Therapeutics, Inc.Novotech (Australia) Pty Limited完全的
-
CHU de Reims完全的